Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant

Cited by (1,000)

Items 801–900 of 1,000

  1. Interplay of gut microbiome, fatty acids, and the endocannabinoid system in regulating development, progression, immunomodulation, and chemoresistance of cancer
    Sourav Kumar Nandi, Sudarshana Basu, Anish Bhattacharjya, Ruma Dey Ghosh, Chinmoy Kr. Bose, Soma Mukhopadhyay, R.K. Bhattacharya · 2022 · Nutrition
  2. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities
    Nicholas A. Lesniak, Sarah Tomkovich, Andrew Henry, Ana Taylor, Joanna Colovas, Lucas Bishop, Kathryn McBride, Patrick D. Schloss · 2022 · mBio
  3. Treatment issues in recurrentClostridioides difficileinfections and the possible role of germinants
    Noah Budi, Nasia Safdar, Warren E. Rose · 2020 · FEMS Microbes
  4. Methodology, efficacy and safety of fecal microbiota transplantation in treating inflammatory bowel disease
    Xiao Lan Ding, Xiaozhong Yang, Honggang Wang · 2020 · Medicine in Microecology
  5. Improving ICI outcomes with a little help from my microbial friends
    Olivia N. Rebeck, Gautam A. Dantas, Drew J. Schwartz · 2021 · Cell Host & Microbe
  6. Refractory ulcerative colitis stabilized by interval washed microbiota transplantation: less is more
    Yun Wang, Bota Cui, Faming Zhang · 2022 · Current Medical Research and Opinion
  7. Fecal microbiota transplants in pediatric autism: opportunities and challenges
    Jian Wang, Rong Yang, Hui Zhong, Yan-Jun Liu · 2024 · World Journal of Pediatrics
  8. Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Where We Stand and What Is Next
    Dai Ishikawa, Xiaochen Zhang, Kei Nomura, Akihito Nagahara · 2025 · Inflammatory Intestinal Diseases
  9. Targeting Gut–Lung Crosstalk in Acute Respiratory Distress Syndrome: Exploring the Therapeutic Potential of Fecal Microbiota Transplantation
    Mairi Ziaka · 2025 · Pathogens
  10. Evaluation of the antibacterial activity of the natural product α-mangostin against Clostridioides difficile
    Brice Jasarino Stolz, Ahmed Adel Abouelkhair, Nader S. Abutaleb, Mohamed N. Seleem · 2026 · PLoS ONE
  11. Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the MITRIC trial
    Andreas Ullern, Kjetil Kjeldstad Garborg, Sudhir Kumar Chauhan, Kristian Holm, Corinna Bang, Claire Dunn, Peter Holger Johnsen, Johannes Espolin Roksund Hov, Jon Amund Kyte · 2026 · Journal for ImmunoTherapy of Cancer
  12. Gastrointestinal and Intra-Abdominal Infections
    Jane E. Sykes, Ingrid M. Balsa, William T. N. Culp, Boaz Arzi, Sina Marsilio, Stanley L. Marks · 2021 · Elsevier eBooks
  13. Live biotherapeutic products: a capstone for prevention of recurrent Clostridiodes difficile infection
    Kanika Sehgal, Paul Feuerstadt · 2024 · Frontiers in Microbiomes
  14. Masks As a New Hotspot for Antibiotic Resistance Gene Spread: Reveal the Contribution of Atmospheric Pollutants and Potential Risks
    Yanjie Wang, Qi Wang, Guodong Zhang, Yutong Li, He Guo, Jian Zhou, Tiecheng Wang, Hanzhong Jia, Lingyan Y. Zhu · 2024 · Environmental Science & Technology
  15. Fecal microbiota spores, live-brpk (VOWST™/VOS) for prevention of recurrent Clostridioides difficile infection
    Parul Berry, Sahil Khanna · 2024 · Future Microbiology
  16. Systematic review of the orally administered microbiome therapeutic, fecal microbiota spores, live-brpk, to prevent recurrence of Clostridioides difficile infection in adults
    Kerry L. LaPlante, Robert Stevens, Anne J Gonzales-Luna · 2024 · SAGE Open Medicine
  17. Oral vancomycin prophylaxis for the prevention of recurrent Clostridioides difficile infection during re-exposure to systemic antibiotics: A systematic review and meta-analysis
    Connor J. Prosty, Émilie Bortolussi‐Courval, Laurie-Rose Dubé, Todd Campbell Lee, Emily Gibson McDonald · 2024 · CMI Communications
  18. Gut Dysbiosis and Fecal Microbiota Transplantation in Pancreatic Cancer: Current Status and Perspectives
    Xiulin Hu, Congjia Ma, Xiangyu Kong · 2024 · Cancer Screening and Prevention
  19. Gut Feelings: Linking Dysbiosis to Depression—A Narrative Literature Review
    Anca C. Bibolar, Vlad-Ionuț Nechita, Florin C. Lung, Bianca Daniela Crecan-Suciu, R. Paunescu · 2025 · Medicina
  20. Impact of fecal microbiota transplantation on chronic recurrent pouchitis in ulcerative colitis with ileo-anal anastomosis: study protocol for a prospective, multicenter, double-blind, randomized, controlled trial
    Caroline Trang, Elise Kerdreux, Alexandra Poinas, Lucie Planche, Harry Sokol, Pascale Bémer, Karine Cabanas, Eliane Hivernaud, Laetitia Biron, Laurent Flet et al. · 2020 · Trials
  21. Follow your Gut: Microbiome-Based Approaches in the Developmental Pipeline for the Prevention and Adjunctive Treatment of Clostridioides difficile Infection (CDI)
    Anne J Gonzales-Luna, Travis J Carlson · 2020 · Current Infectious Disease Reports
  22. Darm-Leber-Achse – wie der Darm die Leber krank macht
    Münevver Demir, Frank Tacke · 2022 · Die Innere Medizin
  23. Monkeypox and fecal microbiota for transplantation(FMT): An unprecedented risk?
    Rabia Owais, Maham Iqbal · 2022 · Annals of Medicine and Surgery
  24. Emerging alternatives against Clostridioides difficile infection
    A. Romero-Rodríguez, C. Martínez de la Peña, Scarlett Troncoso-Cotal, C. Guzmán, S. Sánchez · 2022 · Anaerobe
  25. Das bakterielle intestinale Mikrobiom – Key Player in der Sepsis
    Matthias Lindner, David I. Radke, Gunnar Elke · 2023 · Medizinische Klinik - Intensivmedizin und Notfallmedizin
  26. Cytomegalovirus in donors for fecal microbiota transplantation, the phantom menace?
    Tatiana Galpérine, Ilka Engelmann, Sébastien Hantz, D. Postil, A. Dewilde, Dominique Deplanque, Renaud Martin, Julien Labreuche, Mouna Lazrek, Stéphanie Somers et al. · 2023 · PLoS ONE
  27. Increased Incidence and Risk of Septicemia and Urinary Tract Infection After Clostridioides difficile Infection
    Margaret A A Olsen, Matthew R. Keller, Dustin L. Stwalley, Holly Yu, Erik R. Dubberke · 2023 · Open Forum Infectious Diseases
  28. Role of Fecal Microbiota Transplantation in Managing Clostridium Difficile Infection and Inflammatory Bowel Disease: A Narrative Review
    Haider Ghazanfar, Sameer Kandhi, Trishna Acherjee, Zaheer Ahmad Qureshi, Mohammed Shaban, Diaz Saez Yordanka, Dessiree Cordero, Siddarth Chinta, Abhilasha Jyala, Harish K. Patel · 2023 · Cureus
  29. Beneficial metabolic effects of PAHSAs depend on the gut microbiota in diet-induced obese mice but not in chow-fed mice
    Jennifer Lee, Kerry Wellenstein, Ali Rahnavard, Andrew T. Nelson, Marlena M. Holter, Bethany P. Cummings, Vladimir Yeliseyev, Ângela Castoldi, Clary B. Clish, Lynn Bry et al. · 2024 · Proceedings of the National Academy of Sciences
  30. High prevalence of MDR gram-negative bacteria in feces of healthy blood donors in Mexico
    Karla Maria Tamez-Torres, Alfredo Ponce‐de‐León, Pedro Torres‐González, Esteban Pérez-García, Estefania Torres-Veintimilla, Miriam Bobadilla-del-Valle, José Sifuentes‐Osornio · 2020 · European Journal of Clinical Microbiology & Infectious Diseases
  31. Fecal Microbiota Transplants Annually and Their Positive Clinical Impact
    Lamia Mamoon, Scott W. Olesen · 2020 · Clinical and Translational Gastroenterology
  32. Correlations between microbiota and metabolites after faecal microbiota transfer in irritable bowel syndrome
    Savanne Holster, Dirk Repsilber, D. Geng, Tuulia Hyötyläinen, Anne Salonen, Carl Mårten Lindqvist, Sukithar Rajan, Willem M. de Vos, Robert J. Brummer, Julia König · 2020 · Beneficial Microbes
  33. Pediatric Digestive Health and the Gut Microbiome: Existing Therapies and a Look to the Future
    Samantha A. Saul, Jessika Füssel, Joseph Runde · 2021 · Pediatric Annals
  34. Screening, Diagnosis, and Treatment of Alcohol-Related Liver Disease and Alcohol-Associated Hepatitis.
    Parita Patel, Steven L. Flamm · 2022 · PubMed Central
  35. Prevalence of Multidrug-Resistant Organisms in Healthy Adults in Shenzhen, China
    Ding Liu, Guiqiu Li, Zhifan Hong, Cong Zhang, Ning Zhu, Yan Qin Tan, Ting Gao · 2023 · Health Security
  36. Altering Routine Intensive Care Unit Practices to Support Commensalism
    Leslie A. Hamilton, Michael L. Behal · 2020 · Nutrition in Clinical Practice
  37. Unexpected Results From a Phase 2 Trial of a Microbiome Therapeutic for Clostridioides difficile Infection: Lessons for the Future
    Vincent Bensan Young · 2020 · Clinical Infectious Diseases
  38. Fecal microbial transplant for inflammatory bowel disease
    Jennifer D. Claytor, Najwa El‐Nachef · 2020 · Current Opinion in Clinical Nutrition & Metabolic Care
  39. The gut microbiome and its interaction with health, disease, treatment response and toxicity in patients advanced cancer: focus on lung cancer and immunotherapy
    Nadina Tinsley, Natalie Cook · 2020 · Translational Lung Cancer Research
  40. The challenges and opportunities in the expanding horizons of microbiota transplant therapies
    Alexander Khoruts · 2025 · Gut Microbes
  41. A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper
    Tao Chen, Ashok Kumar Choudhury, Wei Liu, Meng Zhang, Wenhui Wu, Huiling Xiang, Xiaojing Wang, Zaigham Abbas, Tatsuo Kanda, Ramazan Idılman et al. · 2026 · Hepatology International
  42. Unraveling the Intestinal Microbiota Conundrum in Allogeneic Hematopoietic Stem Cell Transplantation: Fingerprints, Clinical Implications and Future Directions
    Alexandre Soares Ferreira, Bianca Fernanda Rodrigues da Silva, Jefferson Luiz da Silva, Mariana Trovao da Silva, João Victor Piccolo Feliciano, Iago Colturato, George Maurício Navarro Barros, Phillip Scheinberg, Nelson Jen An Chao, Gislane Lelis Vilela de Oliveira · 2025 · Journal of Clinical Medicine
  43. Microbial dysbiosis in cholangiocarcinoma
    Yunjia Liu, Shaohui Huang, Yang Zhang, Yuankun Zhang, Yunfei Xu, Yongchang Tang, Sen Guo, Zongli Zhang · 2026 · Frontiers in Microbiology
  44. Gut microbiota and sepsis: mechanisms, clinical correlations, and therapeutic prospects
    Jinmin Yu, Xiaoqing Liu · 2026 · Frontiers in Medicine
  45. Should the Faecal Microbiota Composition Be Determined to Certify a Faecal Donor?
    Celia Morales, Luna Ballestero, Patricia del Río, Raquel Barbero-Herranz, Leticia Olavarrieta, Leticia Gomez-Artiguez, Javier Galeano, José Avendaño Ortiz, Juan Basterra, Rosa del Campo · 2024 · Diagnostics
  46. Beyond Random Fecal Microbial Transplants
    Ryan Balfour Sartor · 2024 · Gastroenterology Clinics of North America
  47. The role of secondary genomes in neurodevelopment and co-evolutionary dynamics
    Siddharth Singh, Vaishali Saini, Hem Chandra Jha · 2025 · International review of neurobiology
  48. Friend or foe: the gut microbiota as a modulator of disease trajectory in trauma, surgery, and critical illness
    Jessica L. Cao, Rebecca S. Meltzer, Ellen Cohn, Andrew Benjamin, Robert C. Keskey, John C. Alverdy · 2025 · Gut Microbes
  49. Role of Ruminococcus gnavus in the elderly with cognitive impairment: A case-control study and an animal experiment
    Yanfei Wei, Yining Huang, Shi-Ao Wang, Kuan Liu, Qi Zhong, Weidong Fan, Bifei Cao, Hao-Wen Chen, Yongqi Liang, Qiurong Li et al. · 2025 · Journal of Alzheimer s Disease
  50. Recent Advances in the Role of Bacteriophages in the Aetiology and Therapy of Vaginal Dysbiosis in the Form of Bacterial Vaginosis and the Prevention of Preterm Birth
    Ronnie Lamont, Amaan Ali, Jan Stener Jørgensen · 2025 · Microorganisms
  51. Pilot Clinical Trial of Fecal Microbiota Transplantation for Constipation in Parkinson's Disease
    Zhaoyu Qiu, Huilu Zhang, Cong Shen, Jie Liu, Jian Wang, Jun Zhang · 2025 · Journal of Microbiology and Biotechnology
  52. Modulating the gut-reproductive tract axis: microbial influence on gynaecological cancer pathogenesis and treatment
    Xinyi Chen, Zhenqiang Zuo, Bingbing Xiao, Fangqing Zhao · 2026 · Gut
  53. The gut microbiota in Salmonella Typhi infection and translocation: Mechanisms of colonization resistance, pathogen subversion, and prospects for microecological intervention
    Chunyu Ma, Ziyi Zou, W Zhao, Yiwei Rao, Boheng Liu, Mengqi Sun, Dengyu Chen · 2026 · Microbial Pathogenesis
  54. Critical role of reproductive tract microbiota and derived metabolites in inflammation, tumor immunity, and tumorigenesis of gynecological cancers: a narrative review
    Hong Chen, Ge Lou, Fanling Meng, Yang Zhang, Hongying Kuang, Dongxia Yang · 2026 · Frontiers in Immunology
  55. Targeting the gut-kidney axis to improve kidney transplantation prognosis: from mechanisms to clinical intervention strategies
    Huanhuan Cao, Jing Sun, Yi Lv, Jiajia Ye, Yumei Wang, Hui Jiang · 2026 · Renal Failure
  56. Microbiota-driven neuroimmune mechanisms in brain disorders: Microglial activation, cytokine signaling, and translational implications
    J. P. Misra, K.S. Shreevatsa, Karthikeyan Ravi, Mosleh Mohammad Abomughaid, Sorabh Lakhanpal, Ramji Gupta, Niraj Kumar Jha, Naveen Kumar · 2026 · Journal of Neuroimmunology
  57. Microbiome-Based Therapies in Ulcerative Colitis: Mechanisms, Clinical Evidence, and a Precision-Medicine Framework
    Philippe Pinton · 2026 · Biomedicines
  58. Advances and challenges in microbiome transplantation
    Paromita Sen, David Kaulmann, Ilan Youngster, Suhaib K. Abdeen, Eran Elinav · 2026 · Cell Host & Microbe
  59. Signal Versus Noise: How to Analyze the Microbiome and Make Progress on Antimicrobial Resistance
    Jonathan L. Golob, Krishna K. Rao · 2021 · The Journal of Infectious Diseases
  60. Multi-Donor Fecal Microbial Transplantation for Critically Ill Patients: Rationale and Standard Operating Procedure
    Veronika Řehořová, Ivana Cibulková, Hana Soukupova, František Duška · 2022 · Future Pharmacology
  61. A Taxonomy-Agnostic Approach to Targeted Microbiome Therapeutics—Leveraging Principles of Systems Biology
    Kyle D. Brumfield, Paul Cox, James D. Geyer, Julius G. Goepp · 2023 · Pathogens
  62. Fecal microbiota transplantation and its repercussions in patients with melanoma refractory to anti-PD-1 therapy: scope review
    Eduardo Cerchi Barbosa, Eduarda Emília Cruz Bucar, GABRIEL RODRIGUES JUBÉ, LETÍCIA BONFIM SILVEIRA, NATÁLIA CÂNDIDO DUAILIBE SILVA, PEDRO CARVALHO CAMPOS FARIA, P Ramos, Vitor Ryuiti Yamamoto Moraes, JOÃO ORMINDO BELTRÃO BARROS · 2023 · Revista do Colégio Brasileiro de Cirurgiões
  63. Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective
    Arghya Samanta, Moinak Sen Sarma · 2024 · World Journal of Hepatology
  64. Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model
    Sadhana Sharma, Vincenzo S. Gilberto, Cassandra L. Levens, Anushree Chatterjee, Kristine A. Kuhn, Prashant Nagpal · 2024 · ACS Pharmacology & Translational Science
  65. Evidences and perspectives on the association between gut microbiota and sepsis: A bibliometric analysis from 2003 to 2023
    Jiahui Hu, Qigu Yao, Linjun Zhao · 2024 · Heliyon
  66. Personalised medicine based on host genetics and microbiota applied to colorectal cancer
    Adriana González, Iker Badiola, Asier Fullaondo, Javier Rodríguez, Adrián Odriozola · 2024 · Advances in genetics
  67. Intestinal M icrobiota Transplant Prior to A llogeneic S tem Cell T ransplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trial
    Benjamin Harvey Mullish, Andrew J. Innes, Lauren A. Roberts, Shian Anim-Burton, Lee Webber, Nicholas Andrew Johnson, Rohma Ghani, Pakhshan Farshi, Anjum Bashir Khan, Francesca A. M. Kinsella et al. · 2024 · BMJ Open
  68. No Beneficial Effects of the Alfasigma VSL#3 Probiotic Treatment After Cervical Spinal Cord Injury in Rats
    Pamela J. F. Raposo, Antoinette T. Nguyen, Emma K. A. Schmidt, Abel Torres Espin, Keith K. Fenrich, David J. Bennett, Karim Fouad · 2025 · Topics in Spinal Cord Injury Rehabilitation
  69. Gut virus axis: Unravelling viral contribution to gut microbiota dysbiosis and translational medicine in inflammatory bowel disease
    Naziya Akhtar, Chirag Jain, Shikha Baghel Chauhan, Indu Prakash Singh · 2025 · Medicine in Microecology
  70. Hospitalized Older Patients with Clostridioides difficile Infection Refractory to Conventional Antibiotic Therapy Benefit from Fecal Microbiota Transplant
    Jae Hyun Shin, R. Ann Hays, Cirle Alcantara Warren · 2021 · Advances in Geriatric Medicine and Research
  71. Validation of High-Sensitivity Severe Acute Respiratory Syndrome Coronavirus 2 Testing for Stool—Toward the New Normal for Fecal Microbiota Transplantation
    Ahmed Babiker, Jessica Ingersoll, Max W. Adelman, Andrew S Webster, Kari J. Broder, Victoria D. Stittleburg, Jesse J. Waggoner, Colleen S. Kraft, Michael H. Woodworth · 2021 · Clinical and Translational Gastroenterology
  72. The levels and core delivery ways of gut microbial reconstruction
    Gaochen Lu, Faming Zhang · 2022 · Scientia Sinica Vitae
  73. Comprehensive bibliometric and visualized analysis of research on fecal microbial transplantation published from 2000 to 2021
    Jing Ma, Ting Chen, Xiangxue Ma, Beihua Zhang, Jiaqi Zhang, Lin Xu, Yifan Wang, Jinke Huang, Zhihong Liu, Fengyun Wang et al. · 2022 · BioMedical Engineering OnLine
  74. Past, Present, and Future Therapies for Alcohol-associated Hepatitis
    Sally Condon, Loretta Jophlin · 2023 · Clinical Therapeutics
  75. Treatment and Management of Gastrointestinal Disorders
    Garren Montgomery, Arsheya Patel, Sheryl A. Pfeil · 2024 · Medical Clinics of North America
  76. The ethicolegal framework relevant to human faecal microbiota transplants in South Africa: Part 1. A legal vacuum
    Melodie Labuschaigne, M Slabbert, Shrish Budree, Ebrahim Hoosien, Adrian John Brink, Marc Blockman · 2020 · South African Medical Journal
  77. Fecal Microbiota Transplant: Latest Addition to Arsenal against Recurrent Clostridium difficile Infection
    Monica Gulati, Sachin Kumar Singh, Leander Corrie, Lipika Chandwani, Apoorva Singh, Bhupinder Kapoor, Rajesh Kumar, Narendra Kumar Pandey, Bimlesh Kumar, Ankit Awasthi et al. · 2020 · Recent Advances in Anti-Infective Drug Discovery
  78. Romanian National Guideline on Translating Fecal Microbiota Transplantation Applications related to Clostridioides difficile Infections into the Local Clinical Practice
    Georgiana-Emmanuela Gîlcă-Blanariu, Gabriela Ștefănescu, Irina Gîrleanu, Tariq H Iqbal, Jonathan Philip Segal, Benjamin Harvey Mullish, Mohammed Nabil Quraishi, Josbert J. Keller, Tamás Molnár, Françis Mégraud et al. · 2021 · Journal of Gastrointestinal and Liver Diseases
  79. Revolutionizing gut health: exploring the role of gut microbiota and the potential of microbiome-based therapies in lower gastrointestinal diseases
    Yong Eun Park, Jae Hyun Kim · 2023 · Kosin Medical Journal
  80. Fecal Transplant: The Benefits and Harms of Fecal Microbiota Transplantation
    David Goldenberg, Gil Melmed · 2023 · Springer eBooks
  81. Le transfert de microbiote fécal : quel potentiel thérapeutique dans le traitement des maladies métaboliques ?
    Tiphaine Le Roy, Judith Aron‐Wisnewsky, Karine Clément · 2020 · Nutrition Clinique et Métabolisme
  82. Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials
    Alberto Enrico Maraolo, Riccardo Scotto, Emanuela Zappulo, Biagio Pinchera, Nicola Schiano Moriello, Salatore Nappa, Antonio Riccardo Buonomo, Ivan Gentile · 2020 · Expert Review of Anti-infective Therapy
  83. Bacterial and viral assemblages in ulcerative colitis patients following fecal microbiota and fecal filtrate transfer
    Howard Junca, Arndt Steube, Simon Mrowietz, Johannes Stallhofer, Marius Vital, Luiz Gustavo dos Anjos Borges, Dietmar Helmut Pieper, Andreas Stallmach · 2024 · ISME Communications
  84. Clostridioides difficile infection study models and prospectives for probing the microbe-host interface
    Tatiana Zvonareva, David S. Courson, Erin B. Purcell · 2025 · Journal of Bacteriology
  85. Risk Factors, Presentation, Diagnosis, and Treatment of C. difficile Infection in the Older Adult
    Elizabeth Reznik, Xiaohan Ying, Carl V. Crawford · 2025 · Current Treatment Options in Gastroenterology
  86. Adverse events after fecal microbiota transplantation in nine cats: a case series
    Mary Ann Lee, Tanner S. Slead, Jan S. Suchodolski, Mary Katherine Tolbert, Sina Marsilio · 2025 · Journal of Feline Medicine and Surgery
  87. Management of gastrointestinal adverse effects in immune-based combination therapy for advanced renal carcinoma: when the oncologist meets the gastroenterologist
    Angelo DEL GAUDIO, Loris Riccardo Lopetuso, Valeria Pavese, Erica Palesandro, Ilaria Campisi, Marcello Tucci, Franco Scaldaferri · 2025 · Therapeutic Advances in Gastroenterology
  88. Bacteria modulate tumor-associated macrophages to combat cancer
    Zonghai Chen, Jingxuan Li, Jing Jing Wang, Yufei Bai, Zhang Zhang, Guofu Chen, Xuan Thang Cao, Dexi Jin · 2025 · Critical Reviews in Oncology/Hematology
  89. Gut microbiota and nutritional interventions in alcohol-associated liver disease: Mechanisms and therapeutic advances
    Ashi Mittal, Shvetank Sharma · 2025 · Nutrition Research
  90. Microbiotherapy and fecal microbiota transplantation in hematology-oncology: a European clinical perspective to navigate the evolving regulatory framework and the emergence of a new therapeutic class
    Florent Malard, Ernst Holler, Zinaida Perić, Varun Mehra, Rafael F. Duarte, Jaime Sanz, Alexandros Spyridonidis, Xavier Poiré, Linde M. Morsink, Johannes Clausen et al. · 2025 · Bone Marrow Transplantation
  91. Next-generation cancer therapies: translating experimental advances into clinical practice
    Eftal Kale, Eren Guzes, Feyzanur Alatas, Parisa Sharafi · 2025 · Postgraduate Medical Journal
  92. Fecal microbiota transplantation in liver diseases: Therapeutic potential and associated risks
    Jayeeta Bhowmick, Arka Bagchi · 2026 · Progress in molecular biology and translational science
  93. The role and possible mechanism of intestinal fungi in the progression of chronic liver diseases
    Yue Hua Hu, Ye Yang, Shuyan Wang, Huikuan Chu · 2026 · npj Biofilms and Microbiomes
  94. The Metabolic Dialogue Between the Gut and Distant Organs: From Microbial Products to Host Responses
    Lei Chen, Mengyao Li, Xin Wang, Wei‐Ting Hu, Yiming Pan, Yun Wang · 2026 · Comprehensive physiology
  95. The gut microbiome as an actionable drug-sensitivity modulator for immune checkpoint blockade: clinical evidence for FMT, live biotherapeutics, and defined consortia
    Wenqian Han, Quanfang Li, Guangwen Yuan · 2026 · Frontiers in Immunology
  96. Influence of Gut Microbiota on Response to Immune Check Point Inhibitors in MASLD Patients With HCC : Unraveling the Connection
    Mazen Elsheikh, Mohamad Ali Ibrahim, Sherry Fares, Megha Bhongade, Karim Adhem, Ximena I. Ramirez-Morales, Ahmed Omar Kaseb, Joseph F. Petrosino, Manal M. Hassan, Prasun K. Jalal · 2026 · Cancer Medicine
  97. One therapy, many targets: redefining ulcerative colitis treatment through fecal microbiota transplantation
    Maria Rynikova, Viktoria Bojcukova, Vlasta Demečková · 2026 · Therapeutic Advances in Gastroenterology
  98. The impact of antibiotic exposure on obesity and metabolic phenotypes via the gut microbiota
    Baogang Zhu, Ce Fu, Dawei Fan, Yan Wang, Pengfang Sheng, Jianghua Feng, Xiaopeng Wang · 2026 · Frontiers in Microbiology
  99. Intestinal Barrier: Mechanisms of Disruption and Strategies for Restoration in Ulcerative Colitis
    Mei-Na Wang, Chuan-Guo Liu, Jia Pan, Xiao-Gang Pang, Huimin Liu · 2026 · Gastrointestinal Disorders
  100. Integration of donor microbiota following FMT correlates with anti-PD-1 response in melanoma
    Jessica L. Fessler, Matthew R. Olm, Edgar G. Engleman, Justin Laine Sonnenburg · 2026 · Nature Communications